Endo International plc: ENDO REPORTS SECOND-QUARTER 2022 FIN

DUBLIN, Aug. 9, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the second-quarter ended June 30, 2022. SECOND-QUARTER FINANCIAL PERFORMANCE (in

Related Keywords

Canada , Dublin , Ireland , Canadian , , Prnewswire Endo International , Branded Pharmaceuticals , Paladin Labs Inc , Linkedin , Company Net Debt Leverage Ratio , Generic Pharmaceuticals , Endo Investor Relations Department , Nasdaq , Exchange Commission , International Pharmaceuticals , Pfizer Inc , Endo International , Company Loss , Months Ended June , Diluted Net , Diluted Net Income , Continuing Operations , Diluted Weighted Average Shares , Adjusted Income , Weighted Average Shares , Adjusted Diluted Net Income , Sterile Injectables , Paladin Labs , Condensed Consolidated Statement , Condensed Consolidated Balance Sheet , Cash Flow , Qualified Settlement , Current Report , Supplemental Financial Information , Condensed Consolidated Statements , Net Debt Leverage Ratio , Net Debt , Restricted Cash , Net Debt Leverage , Debt Leverage Ratio , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Kendo , Nternational , Reports , Second , Quarter , 022 , Financial , Results ,